OtherNEUROPHARMACOLOGY
S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties
Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco
Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 148-161;
Mark J. Millan
Stephan Hjorth
Rosario Samanin
Rudy Schreiber
Robert Jaffard
Brigitte De Ladonchamps
Sylvie Veiga
Bertrand Goument
Jean-Louis Peglion
Michael Spedding

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 282, Issue 1
1 Jul 1997
OtherNEUROPHARMACOLOGY
S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties
Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco
Journal of Pharmacology and Experimental Therapeutics July 1, 1997, 282 (1) 148-161;
OtherNEUROPHARMACOLOGY
S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties
Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco
Journal of Pharmacology and Experimental Therapeutics July 1, 1997, 282 (1) 148-161;